Dietary Supplement
Medium-chain triglycerides
Medium-chain triglycerides is a dietary supplement with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DIETARY SUPPLEMENT
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph early_phase_1
1
25%
Ph not_applicable
3
75%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
N/ANon-phased studies
3(75.0%)
Highest Phase Reached
Early Phase 1Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Other(1)
Detailed Status
Completed3
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Early Phase 1
Trials by Phase
Early Phase 11 (25.0%)
N/A3 (75.0%)
Trials by Status
completed375%
unknown125%
Recent Activity
0 active trials
Showing 4 of 4
unknownnot_applicable
Vitamin D Supplementation in Healthy Adults in Prolonged Endurance Exercise
NCT05781620
completednot_applicable
Vitamin D in Healthy Adults After Strenuous Endurance Exercise
NCT05779410
completednot_applicable
Effects of Medium-Chain Triglycerides on Chylomicron Secretion and Expression of Genes That Regulate Intestinal Lipid Metabolism in Men With Dyslipidemia Associated With the Metabolic Syndrome
NCT01806142
completedearly_phase_1
Ketones & Mitochondrial Heteroplasmy
NCT01252979
Clinical Trials (4)
Showing 4 of 4 trials
NCT05781620Not Applicable
Vitamin D Supplementation in Healthy Adults in Prolonged Endurance Exercise
NCT05779410Not Applicable
Vitamin D in Healthy Adults After Strenuous Endurance Exercise
NCT01806142Not Applicable
Effects of Medium-Chain Triglycerides on Chylomicron Secretion and Expression of Genes That Regulate Intestinal Lipid Metabolism in Men With Dyslipidemia Associated With the Metabolic Syndrome
NCT01252979Early Phase 1
Ketones & Mitochondrial Heteroplasmy
All 4 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 4